HSIC - Henry Schein Inc

NYSE * Health Care * Health Care Providers & Services

$80.21

$-1.16 (-1.43%)

About Henry Schein Inc

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

HSIC Key Statistics

Market Cap

$9.73B

P/E Ratio

24.53

P/B Ratio

2.85

EPS

$3.27

Revenue Growth

+0.1%

Profit Margin

0.0%

Employees

25,000

How HSIC Compares to Peers

HSIC has the lowest P/E ratio in Health Care Providers & Services, suggesting it may be the most undervalued
HSIC is the smallest among peers, which may offer higher growth potential

P/E Rank

#1

of 2

Margin Rank

#2

of 2

Growth Rank

#2

of 2

Size Rank

#2

of 2

CompanyP/EGrowthCompare
HSIC24.50%-
AMZN29.10%vs AMZN

Henry Schein Inc Company Information

Headquarters
New York; U.S.A
Website
www.henryschein.com
Sector
Health Care
Industry
Health Care Providers & Services
Data Updated:
Ready to invest in HSIC?

Commission-free trading available. Affiliate links.

HSIC Lician Score

10% confidence
5.0/10
Neutral

HSIC has a Lician Score of 5/10 (Average). The stock shows average characteristics across all dimensions.

value

5.0

growth

5.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates HSICacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

HSIC Financial Snowflake

5-axis analysis across key investment dimensions

5.0/10

Neutral

35810Value5.0Growth5.0Quality5.0Momentum5.0Safety5.05.0/10
5.0

Value

5.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for HSIC